ArticleInternational journal of general medicine2025
High Pan-Immune Inflammation Values are Associated with Prolonged Length of Hospital Stay in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Predictive Value of SAPS II for 28-Day All-Cause Mortality in AECOPD Patients Admitted to the ICU.International journal of chronic obstructive pulmonary disease · 2026Article
- Pan-immune inflammation value and system inflammation response index associated with prolonged hospital stay of thyroid nodule patients undergoing ultrasound-guided microwave ablation, both aged ≤55 years and > 55 years.Frontiers in endocrinology · 2026Article
- Validation of China's 2025 high-risk criteria in RT-PCR-confirmed chikungunya inpatients: a single-centre retrospective cohort.BMC infectious diseases · 2025Article
- The Role of Emerging Immune-Inflammatory Indexes in the Preoperative Differentiation of Complicated and Uncomplicated Acute Appendicitis: A Single-Center Retrospective Analysis.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Inflammation is a major contributor to prolonged hospital stays, increased healthcare costs, and poor prognosis in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This study aimed to investigate the relationship between the Pan-Immune Inflammation Value (PIV), a novel immune-inflammatory biomarker, and the prolonged hospital stays in patients hospitalized for the first time with AECOPD to provide an effective risk assessment tool for clinical practice. Patients and Methods: We retrospectively analyzed clinical data from 5810 patients admitted to the Affiliated Dongyang Hospital of Wenzhou Medical University between January 2010 and March 2024, with AECOPD as the primary diagnosis. Prolonged hospital stay was defined as a stay exceeding the 75th percentile for all included patients (length of hospital stay > 10 days). The association between PIV and prolonged hospital stay in patients with AECOPD was assessed using multi-model logistic regression analysis, restricted cubic spline (RCS) curves, and subgroup analysis. Results: Higher log Conclusion: PIV is a potential biomarker for predicting prolonged hospital stay in patients hospitalized for the first time with AECOPD, providing a new assessment tool for clinical practice. The results of this study can help guide clinical decision-making, optimize treatment strategies, improve patient prognosis, and provide a scientific basis for the rational allocation of healthcare resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.